- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
NIH Defends Grant to Sanctioned Psychiatrist
13 August 2012 4:57 pm
The National Institutes of Health (NIH) is defending its decision 3 months ago to award a research grant to Charles Nemeroff, the former Emory University psychiatrist who got into trouble for failing to tell his university about at least $1.2 million in consulting income from drug companies.
After Emory barred him from receiving grants for 2 years in December 2008, Nemeroff moved on to the University of Miami. In May, he won a 5-year, $401,675-a-year grant to study posttraumatic stress disorder. As reported today by the blog Pharmalot, NIH wrote Senator Charles Grassley (R-IA) on 3 August in response to a query about the matter. One of Grassley's questions was why NIH had awarded the grant even though Nemeroff was being investigated by the Department of Health and Human Services’s Office of Inspector General (OIG) and the Department of Justice.
In a 3 August letter to Grassley, NIH Deputy Director Lawrence Tabak explains that OIG and Justice investigations are confidential and peer reviewers weren't told about the review. "Absent any finding by the OIG or other actionable grounds at this time to exclude Dr. Nemeroff, the NIH followed standard procedures," the letter says.
Tabak also explains that Nemeroff's proposal went through usual reviews for scientific and public health value and that NIH asked the University of Miami about potential conflicts of interest involving the research. The letter notes that the study doesn't involve testing drugs. It also says that Thomas Insel, director of the National Institute of Mental Health, who has historical ties to Nemeroff, recused himself from the review. "I want to assure you that all procedures have been followed carefully in the process of awarding this specific grant to the University of Miami," Tabak wrote.
As part of the documents it gave Grassley, NIH included a "talking points" memo indicating that NIH was ready for criticism. The memo describes which officials should respond to questions about the grant and includes information similar to that in the letter to Grassley. It also says that the total grant is $690,000 a year for 5 years for a study at two sites—the University of Miami and Emory.
11:40 a.m., 14 August: Due to concerns about possible misuse, the image of the handwritten signature on Lawrence Tabak's letter has been obscured.